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Abstract
Background: It is infeasible to occlude a doubly committed juxtaarterial ventricular septal defect (DCVSD)
percutaneously. The previous perventricular device closure technique was performed through an inferior
median sternotomy approach. The purpose of this study is to evaluate the feasibility, safety and efficacy of
perventricular device closure of DCVSDs through a left parasternal approach.
Methods: Sixty-two patients, with the DCVSD of less than 6 mm in diameter, were enrolled in this study. The
pericardial space was approached through a left parasternal mini-incision without entering into the pleural
space. Two parallel pursestring sutures were placed on the right ventricular outflow tract for puncture. Under
transesophageal echocardiographic guidance, a new delivery sheath loaded with the device was inserted into
the right ventricle and advanced through the defect into the left ventricle. The device, connected with a
device stay suture, was deployed subsequently.
Results: Successful device closure of the defects was achieved in 58/62 patients (94 %). The DCVSD failed to
close in 4 (6 %) patients due to device-related aortic regurgitation and device migration. The mean DCVSD diameter
was 3.4 ± 1.0 mm (range, 2.0 to 6.0 mm). The implanted device size was 5.2 ± 1.3 mm (range, 4 to 8 mm). Forty-four
out of 58 patients (76 %) was implanted with an eccentric occluder. The mean intracardiac manipulation time was 14
± 13 min (range, 2 to 60 min). The procedure time was 66 ± 15 min (range, 42 to 98 min). During the follow-up period
of 180 to 1860 (median 880) days, new mild pulmonary regurgitation occurred in 2 patients. No other device-related
complications were found. The complete closure rate was 95 % at discharge, 98 % at 1-, 6- and 12-month, 96 % at 2-year,
and 100 % at 3-year follow-up.
Conclusions: Perventricular device closure of a DCVSD through a left parasternal approach is feasible, safe, and efficacious
in selected patients. This minimally invasive technique permits easy defect crossing and accurate device positioning.
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Background
Percutaneous closure of ventricular septal defects (VSDs)
using Amplatzer septal occluders has been shown to be
safe and efficacious. It is generally accepted that perimem-
branous and muscular VSDs can be occluded with excel-
lent results [1–3]. However, device closure of a doubly
committed juxtaarterial ventricular septal defect (DCVSD)
is difficult to succeed in percutaneous approach because
of the specific anatomy of the defect, which is located at
the infundibular septum. No reports have been published
on percutaneous device closure of DCVSDs until now.
In recent years, perventricular device closure of peri-
membranous VSDs has been developed and applied clin-
ically with good results [4–7]. However, fewer reports
have been published on perventricular device closure of a
DCVSD, especially the midterm follow-up results. More-
over, the previous technique was performed through an
inferior median sternotomy approach [8, 9]. The lower half
of the sternum has to be split open for exposure the punc-
ture site at the right ventricular outflow tract. Operative
trauma is still remarkable. Postoperative pain and the pec-
tus carinatum deformity are common after this procedure.
The purpose of this study is to evaluate the feasibility,
safety and efficacy of using a new minimally invasive tech-




Between May 2009 and November 2014, 62 patients under-
went perventricular device closure of DCVSDs through a
left parasternal approach in our hospital. Baseline noninva-
sive data were obtained by physical examinations, electro-
cardiography, transthoracic echocardiography (TTE), and
chest radiography. The DCVSD was defined as a defect that
located at the 12:30 to 2 o’clock position in the parasternal
short-axis view on TTE [10]. Fifteen patients had symptoms
of recurrent respiratory infection, palpitations, or exercise
intolerance. Sixteen patients had a trivial or mild aortic
regurgitation. The DCVSD coexisted with a mirror image
dextrocardia in 1 patient.
According to their age, the patients were divided into two
groups: 35 patients younger than 5 years were included as a
younger age group and the remaining 27 were included as
an older age group.
Indications for DCVSD closure were the same as those
used for surgical closure, which included hemodynamically
significant left to right shunts, left ventricular chamber en-
largement, and (or) mild to moderate pulmonary hyperten-
sion. The inclusion criteria for device closure of DCVSDs
included: 1) age of 6 months or older; 2) a maximum diam-
eter of the DCVSD of less than 6 mm and 3) left to right
shunt. Exclusion criteria included patients with the defect
size of more than 6 mm, aortic valve prolapse, moderate or
severe aortic regurgitation, intracristal muscular VSD in the
outlet septum, contraindications to antiplatelet therapy,
and those coexisting with other cardiac anomalies. The
enrolled patients or their guardians hoped to close the de-
fect, eliminate the heart murmur, reduce the risk of aortic
prolapse, and have a cosmetic procedure. Once a patient
met the enrollment criteria, he/she or the guardian was
fully informed of the available treatment options. Informed
consent was obtained from each patient or from his or her
parents. The study was approved by the ethics committee
of our institution and performed in compliance with the
institutional guidelines and those of the American Physio-
logical Society. The baseline characteristic data of both
groups are shown in Table 1.
Device and delivery system
The closure device used in this study was a modified
double-disk occluder (Starway Medical Technology, Inc.
Beijing, China), based on the Amplatzer septal occluder.
There were two types of devices used in this study: the
concentric occluder with the left disk 2 mm larger than
the connecting waist and the eccentric occluder with the
left disk exceeding the connecting waist by 0 mm in its
superior part and by 4.0 mm in its inferior part. The
right disk is 2 mm larger than the waist in both devices.
The waist of the modified occluder, which is 3 mm in
length, is longer than that of the Amplatzer occluder.
The new delivery system, which is called direct delivery
system (DDS), consists only of a short delivery sheath with
a side arm for removal of air and a delivery cable. The
delivery sheath is about 10 to 15 cm long, ranging from 5
to 10 F in size (Fig. 1a).
Transesophageal echocardiography (TEE) and device
selection
A PHILIPS IE33 echocardiography instrument (Philips
Healthcare, Best, The Netherlands) with a 2.0 to 7.0 MHz
frequency conversion probe was used.
After general anesthesia and intubation, patients were
placed in a supine position. The defect size and the mar-
gins adjacent to the aortic valve (the subaortic rim) and
pulmonary valve were measured in the left ventricular
long-axis view, 5-chamber view and short-axis view on
TEE. The integrity of the aortic and pulmonary valve
was assessed simultaneously.
The device selection is determined according to the
size and the subaortic rim of the defect. If the subaortic
rim is at least 1 mm, a concentric occluder was tried
first with the size 1 mm larger than the maximum size
of the defect. If the subaortic rim is less than 1 mm, an
eccentric occluder is selected with the size 2 to 3 mm
larger than the maximum diameter of the defect.
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Procedure
The DCVSDs were occluded perventricularly using the
DDS. The selected device was screwed onto the delivery
cable and pulled inside the delivery sheath under water
with the tip extruded out of the sheath. A device stay su-
ture of 4–0 or 5–0 polypropylene (Ethicon, Somerville, NJ)
was passed through the wire mesh of the device under the
microscrew and pulled out of the sheath. The eccentric
occluder was adjusted to keep the platinum marker on the
left disk towards the side arm before it was retracted into
the sheath (Fig. 1b).
A 1.5 cm to 3 cm parasternal incision was made in
the left second or third intercostal space (within the
“bikini lines” in female patients; Fig. 2). Superficial
tissues were opened with blunt dissection without en-
tering into the pleural space. Exposure was optimized
with a mini-retractor. The pericardium was incised
and cradled. The puncture site was chosen at the
infundibular anterior wall of the right ventricle just
below the pulmonary annulus. Two parallel purse-
string sutures of 4–0 or 5–0 polypropylene were
placed at this site.
Table 1 Clinical data and outcome for the 58 successful patients
Variable Total Younger age group Older age group p value
Patients’ number 58 32 26 —
Median age (yrs) 4.0 (range, 0.5–53.0) 2.0 12.0 —
Sex (F/M) 15/43 7/25 8/18 —
Median weight (kg) 19 (range, 6–80) 13 39 —
DCVSD size (mm) 3.4 ± 1.0(range, 2.0–6.0) 3.2 ± 0.9 3.6 ± 1.2 —
LVEDD before operation (cm) 3.8 ± 0.8(range,1.9–5.6) 3.2 ± 0.4 4.5 ± 0.5 —
LVEDD at discharge (cm) 3.5 ± 0.7(range,1.8–5.2)a 3.0 ± 0.4 4.1 ± 0.6 0.073a
Device size (mm) 5.2 ± 1.3 (range, 4–8) 5.0 ± 1.0 5.3 ± 1.5 —
ICMT (min) 14 ± 13 (range, 2–60) 12 ± 8 17 ± 17 0.157
Procedure time (min) 66 ± 15 (range, 42–98) 59 ± 11 74 ± 16 0.0004
Eccentric occluder (n) 44 26 18 0.450
Concentric occluder (n) 14 6 8 —
Drainage tube placement (n) 19 8 11 0.265
DCVSD doubly committed ventricular septal defect; LVEDD left ventricular end-diastolic diameter; ICMT intracardiac manipulation time
acompared with the LVEDD before operation
Fig. 1 a Direct delivery system. b The eccentric occluder with a device stay suture (magnification of inset 2.5×) was adjusted to keep the
platinum marker on the left disk towards the sheath’s side arm
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After anticoagulation with heparin (100U/kg), the de-
livery sheath loaded with the device was inserted into
the right ventricle through the puncture site. Usually,
the sheath was perpendicular to the septum and directed
towards the defect. Under continuous TEE guidance, it
was advanced through the defect into the left ventricle.
Then the device was deployed and released following the
previous reports [4–8].
During the deployment of an eccentric occluder, the
side arm of the sheath was kept directing towards the
apex (Fig. 3). Then the platinum marker on the left disk
was approximately pointing towards the apex. Figure 4
demonstrates the different steps of perventricular device
closure of a DCVSD.
A complete TEE study was performed. The degree of a
residual shunt was assessed by measuring the width of
the color jet as previously reported [11]. The device was
inspected repeatedly by a push-pull maneuver and re-
leased only when its proper position was obtained and
interference with the aortic and pulmonary valve had
been excluded. The device stay suture was kept for
15 min to observe the device location before it was re-
moved. Then the sheath and cable were withdrawn with
the pursestring sutures snugly tied. The pericardium was
re-approximated without a drainage tube placement if
the operative field was clean and dry. Otherwise, a cen-
tral venous catheter used as a drainage tube was placed
in the pericardium. The incision was closed in layers.
Patient follow-up
Prophylactic antibiotics were started before the procedure
and continued for 2 days. Most patients were discharged 3
to 5 days after the procedure and maintained on aspirin
(3–4 mg · kg−1 · d−1) for the duration of 3 months. The
follow-up protocol included assessments by electrocardi-
ography and TTE at discharge, 1, 3, 6, 12 months and
yearly after the procedure.
Statistical analysis
All data were expressed as median (or mean ± stand-
ard deviation) and range. Intracardiac manipulation
time was defined as the time the delivery sheath en-
tered the right ventricle until the delivery sheath and
cable were withdrawn from the right ventricle. The
intracardiac manipulation time, procedure time, left
ventricular end-diastolic diameter, postoperative hos-
pital stay, defect and device size were recorded. Statis-
tical comparisons of proportions were analyzed using
a chi-square test (Stata10.0 software; StataCorp LP,
Fig. 2 A 1.5 cm parasternal incision in a pediatric patient (a) and a 2.5 cm incision in an adult female patient (b)
Fig. 3 The delivery sheath loaded with the device was inserted into the
right ventricle through the left second intercostal space. The side arm of
the sheath was kept directing towards the apex during deployment
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College Station, TX). A probability value of less than
0.05 was defined as statistical significance.
Results
Intraoperative results
Successful device placement was achieved in 58/62 pa-
tients, with an immediate success rate of 94 %. Fifty-
three of these patients had undergone this procedure
through left second intercostal space except 4 adult
patients through left third interspaces. The patient, who
was associated with a mirror image dextrocardia, success-
fully underwent such a closure through the right second
intercostal space. The procedural data and outcome for
the successful patients are listed in Table 1.
Correct placement of the device at the first attempt
was achieved in 44 patients (76 %). Redeployment of
the device was necessary in 14 patients (24 %). Among
them, the device was replaced with a smaller or eccen-
tric occluder in 8 patients as a result of the encroach-
ment on the aortic valve. The small eccentric was
replaced with a larger one in 6 patients as a result of
the unstable position.
The DCVSD failed to close in 4 patients (7 %). Two
patients, one of whom had a bicuspid aortic valve, were
switched to open repair as a result of device-related
aortic regurgitation. The other two were converted to
an open approach due to device migration and tilting
after release.
Postoperative and follow-up results
All successful patients were extubated within 2 h. Blood
transfusion was not required in each case. Six cases of
mild to moderate pericardial effusion occurred postoper-
atively because of no placement of a drainage tube. They
all recovered after pericardiocentesis or taking diuretics
1 month later. Compared with the preoperative value, 48
patients had a decrease in left ventricular end-diastolic
diameter at discharge (p = 0.073). Postoperative hospital
stay was 4.3 ± 1.0 (range, 3–6) days.
All patients were followed up for a period of 180 to
1860 days (median 880 days) with TTE and electrocardi-
ography—58 patients for 1 and 6 months, 42 for 1 year,
28 for 2 years, and 14 for 3 years. The follow-up rate
was 100 %. Pre-existing aortic regurgitation remained
unchanged or disappeared during the follow-up period.
Device-related aortic regurgitation was not found. New
mild pulmonary regurgitation occurred in 2 cases, which
remained stable during the follow-up periods. Thrombosis,
hemolysis, infective endocarditis or conduction abnormal-
ities were not encountered. Of the successful 58 patients,
Fig. 4 Different steps of perventricular device closure of a small doubly committed ventricular septal defect (DCVSD). a A small DCVSD (arrowhead)
located at the 1 to 2 o’clock position in the parasternal short-axis view on transthoracic echocardiography. b The delivery sheath (arrowhead), which
was perpendicular to the septum, was loaded with the device and passed through the defect. c The left disk was opened with its platinum marker
(arrow) pointing towards the apex. While maintaining gentle tension on the cable without rotation, the delivery sheath was withdrawn to deploy the
right disk of the device into the right ventricle. d The eccentric occluder was placed in a proper position without affecting the aortic and pulmonary
valves. (AV = aortic valve, PV = pulmonary valve)
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50 (86 %) had a complete closure, 8 (14 %) had a trivial or
small residual shunt immediately after device release. The
shunts disappeared during the follow-up period except one
patient. At the last echocardiographic evaluation during
follow-up, the complete closure rate was 95 % at discharge,
98 % at 1-, 6-, and 12-month, 96 % at 2-year and 100 % at
3-year (Table 2).
Discussion
DCVSD is the least common type of VSD in the Western
Hemisphere, accounting for approximately 5 % of such de-
fects. But it is much more common in patients of Eastern
Asian descent (about 25 % of Asian patients with a VSD).
Its location near the aortic and pulmonary valves accounts
for the unique features associated with this defect. Lack of
support for the right aortic leaflet is crucial to the develop-
ment of aortic valve prolapse or regurgitation. Moreover,
spontaneous closure of this defect is not common. There-
fore, numerous practitioners suggest that the DCVSD
should be closed as soon as possible [12, 13].
Perventricular versus percutaneous approach
Surgical repair remains the preferred treatment with
good clinical outcomes. However, it is associated with
morbidity, discomfort, and an unsightly scar. Cardiopul-
monary bypass is needed, which is widely recognized as
having a number of adverse effects.
Although percutaneous closure of VSD by different
devices has been reported for more than 20 years with
good results [1–3], it was mainly performed in patients
with the perimembranous or muscular type of VSD. An
arteriovenous guide-wire loop has to be established.
Sometimes it is even impossible to perform the interven-
tion, due to patient’s low weight or vascular access issues.
Another important concern of percutaneous closure tech-
nique is the exposure to radiation which is associated with
a spectrum of malignancy especially in children [14, 15].
In recent years, a number of reports on perventricu-
lar device closure of perimembranous VSDs have been
published with encouraging results [4–7]. Compared
with the percutaneous approach, the perventricular
approach has the advantages of a short entry route, no
weight and no age limitations, excellent manipulability
of a short delivery sheath, no need to establish an ar-
teriovenous guidewire loop, simple process of recap-
ture and redeployment of the device, and no exposure
to radiation.
In patients with a DCVSD, the spiraling course of the
ventricular septum makes the percutaneous closure
more difficult. Proper positioning of closure devices re-
quires precise definition of septal and valvar anatomy,
which is poorly defined by angiography. The perventri-
cular technique is performed under TEE which is cap-
able of imaging details of intracardiac anatomy as well as
closure devices. The perventricular approach makes it
possible for the sheath to pass through the defect easily
and to position the device precisely.
Advantages of the parasternal over inferior median
sternotomy approach
1. Although the skin incision of the inferior median
sternotomy is small, the length of underlying partial
sternotomy is usually 3 to 5 cm longer than the
length of skin incision. Bleeding due to the
sternotomy is inevitable. A pericardial drainage tube
is needed in each case. Postoperative pain and the
pectus carinatum deformity are common after this
procedure [7, 16]. The parasternal approach is
performed through an intercostal access port
without entering into the pleural space. In most
cases, there is no need of a drainage tube. Therefore,
the parasternal approach leads to less operative
trauma, less pain, less blood loss and better cosmetic
results.
2. The plane of the infundibular septum lies almost
perpendicular to that of the remainder of the
septum. The inferior partial sternotomy incision is
unable to provide an entry route which is
perpendicular to the infundibular septum unless the
















Pre-existing AR (n = 16) 12 9 7 6 4 2 1
New AR (n) 0 0 0 0 0 0 0
New mild PR (n) 2 2 2 2 1 1 0
Complete Closure (%) 50/58 (86) 55/58 (95) 57/58 (98) 57/58 (98) 41/42(98) 27/28(96) 14/14(100)
Trivial RS (%) 6/58 (11) 1/58 (2) 0 0 0 0 0
Small RS (%) 2/58 (3) 2/58 (3) 1/58 (2) 1/58 (2) 1/42 (2) 1/28(4) 0
Follow-up median (days) 880 (180–1860)
IADR immediately after device release; AR aortic regurgitation; PR pulmonary regurgitation; RS residual shunts
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incision is extended superiorly to expose the
infundibular wall of the right ventricle [8]. However,
the left second intercostal access port faces directly
towards the pulmonary annulus. During deployment
of the device, the septum is approached from an
anterior and not a lateral plane. This makes the DDS
more perpendicular to the infundibular septum,
resulting in easier defect crossing and accurate
device positioning.
3. Once the perventricular closure fails, the patient is
converted to a surgical repair directly. A reversed
hockey stick incision is made by extending the original
incision downward from the left second interspaces to
the mid-sternum. The skin and subcutaneous tissue
over the manubrium is mobilized and retracted for
performing a full median sternotomy. The upper
curved part of the skin incision, which can be covered
by the low collar, also provides cosmetic results.
Feasibility and safety
The DCVSD is near the aortic and pulmonary valve.
Three important concerns are involved in the device
closure technique: (1) the left disk might impinge on the
aortic valve, (2) the right disk might affect the pulmon-
ary valve, and (3) the device position might be unstable
after release. Thus, in the previous reports [17], the
DCVSD is not an indication for device closure.
The DDS, which is perpendicular to the septum and
easy to manipulate, facilitates appropriate orientation of
the eccentric occluder with regard to the aortic valve
and cardiac apex. In the DCVSDs of less than 6 mm in
diameter, the superior part of the left disk has no or rela-
tively small contact area with the aortic valve. Thus the
device does not interfere with the aortic valve. If a new
aortic regurgitation were found after device positioning,
the device would be recaptured and replaced with a
small or eccentric one.
A DCVSD has no or a short muscular rim between
the defect and the pulmonary valve annulus [17]. Usu-
ally, the small-sized DCVSD lies beneath commissure
between right and left leaflets of the pulmonary valve.
There is a subcommissural triangle between the right
and left leaflets of the pulmonary valve, separating the
right disk from the pulmonary valve. And the pulmonary
annulus is a little bit higher than the aortic annulus.
These decrease the risk of encroachment of the right
disk on the pulmonary valve.
Although the aortic and pulmonary rim is deficient, the
rest circumferential rim can provide enough support to
the occluder in the small-sized DCVSDs. As described
above, this approach has many additional advantages: the
perpendicular short entry route, the ability to make fine
adjustments in device position, the reliability to test device
stability, and the ability to retrieve a suboptimally placed
device. In order to avoid device embolization, the device
stay suture is applied to all patients in our study. The
suture has improved the safety of this technique. It helps
to retrieve the device through a larger delivery sheath if
the device is dislocated after release.
Pitfalls with the parasternal approach
(1) Because the parasternal approach provides better opera-
tive exposure in pediatric than in adult patients, the ICMT
(p > 0.05) and procedural time (p < 0.01) were shorter in the
younger than in the older age group. (2) The incision can-
not be made too close to the left border of the sternum to
avoid injuring the left internal mammary artery [18]. The
exact location of the incision is determined according to
the chest film and TTE. The level of pulmonary annulus of
adult patients seems lower than that of pediatric patients.
Four adult patients underwent this procedure through the
third intercostal space in this series. (3) Trivial or small
residual shunts can be ignored in device closure technique
as they usually disappear spontaneously during the follow-
up period. (4) If the operative field is not clear and dry,
a pericardial drainage tube is required to prevent peri-
cardial effusion. (5) Pre-existing trivial or mild aortic
regurgitation is not a contraindication for device clos-
ure of the DCVSDs. In some cases, it may disappear
during the follow-up period.
Study limitations
This study is not a prospective randomized study com-
paring the parasternal approach with inferior median
sternotomy or percutaneous approach. We just specu-
lated its safety and advantages according to the previous
reports, our experience and results in our study. We re-
ported only 58 successful patients using this technique
and only 28 of them had been followed for more than
2 years. Further studies are required to establish long-
term results in a larger patient population.
Conclusions
Our study has demonstrated that perventricular device
closure of a DCVSD with the size of less than 6 mm is
feasible, safe and efficacious through a left parasternal
approach. This minimally invasive technique permits
easy defect crossing and accurate device positioning.
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